Meet the Faculty
Dr. Elamin Abdelgadir is an endocrinologist at Dubai Hospital – Dubai Health Authority
Dr. Abdelgadir is a fellow of American College of Endocrinology, fellow of American college of physician, and fellow of Royal college of physicians of Edinburgh.
He is licensed Thyroid and neck sonographer from the American College of Endocrinology.
He is a member of an active research group and he has published over 60 original articles and abstracts.
Dr. Abdelgadir is a member of various regional and international conferences scientific and organizing committees. And he is the former secretary general of the Sudan Diabetes Association – Gulf Chapter.
Elham Al Amiri
Dr. Elham Al Amiri is a Pediatric consultant and chief of Diabetes and endocrine unit at Al Qassimi Women and Children Hospital, Sharjah. Dr. Al Amiri is also an Adjunct Associate Professor in College of Medicine, University of Sharjah. She has obtained her medical degree from King Faisal University in Saudi Arabia, followed by Masters of Science degree in Pediatrics from Trinity College, Dublin and Membership of the Royal College of Pediatrics and Child health (MRCPCH) from UK. She has obtained her ESPE clinical fellowship in pediatric endocrinology in Manchester-UK. She has established the pediatric endocrine and diabetes unit, serving as the only referral center in the Ministry of Health and prevention.
In 2009 Dr Al Amiri founded “Friends for Diabetes” a volunteer support society by a decree from the government of Sharjah.
She was the first author in one of the UAE diabetes landmark researches was on the prevalence, risk factors, and screening measure for prediabetes and diabetes among Emirati overweight/obese children and adolescents
Dr Al Amiri has received several awards; the last being Sheikh Mohammad Bin Rashid Excellence award of best Physician January 2017
Fatheya Al Awadi
Consultant Endocrinologist & the Head of the Endocrine Department-Dubai
• Director of Medical Divisions , Dubai Hospital
• President of Emirates Diabetes Society
• Chairperson of Diabetes Combat and Control Committee – DHA
• Member of National Diabetes Committee
• Associate professor at Dubai Medical College & Sharjah University
• Federation lead Royal college , PACES in Dubai &Sharjah .
• Chief Editor of Dubai Diabetes & Endocrine Journal- DHA
• Actively involved in various studies in diabetes and endocrinology with several
publications in the field .
Khaled Al Dahmani
Dr.Khaled Aldahmani is a consultant endocrinologist at Tawam hospital and an adjunct associate professor at the college of Medicine and health sciences, UAE University.
He obtained his medical degree from UAE University and then completed his internal medicine residency training at university of British Columbia in Canada. He then finished his subspecialty training in endocrinology and metabolism at Dalhousie University followed by a one year combined clinical and research fellowship training in pituitary disorders and thyroid cancer at the same university. He is an American and Canadian board certified in internal medicine and endocrinology.
Dr. Aldahmani is the scientific committee chairperson of Emirates Diabetes and Endocrinology Society (EDES). He is also a board member of Gulf Association of endocrinology and diabetes (GAED). He is a founding member and chairman of the Al-Ain Internal medicine research conference since 2016.
He has special interest in pituitary and thyroid disorders as well as general endocrinology.
Juma Al Kaabi
BSc, MBChB, DTM&H, FRCP, FACP,FACE
Acting Dean of College of Medicine and Health Sciences,
Professor of Medicine, Consultant Internist and Endocrinologist,
UAE University, P.O. Box 17666
AL AIN, United Arab Emirates.
Dr. Alkaabi is a Professor of Medicine at the College of Medicine and Health Sciences, UAE University and Acting Dean of the College of Medicine and Health Services. He also has a co-appointment as a Consultant Internist, Endocrinologist at Tawam Hospital and Al-Ain Hospitals. Dr. Alkaabi is the vice-president of the Emirates Diabetes Society and Founder, Member and Former President of the American Association of Clinical Endocrinologists (AACE)-Gulf Chapter (2012 to 2019). Prof. Alkaabi obtained his basic medical science degree from the University of St. Andrews Scotland in 1990 and his medical degree from University of Manchester- England in 1993. He subsequently trained in Internal Medicine in the United Kingdom followed by clinical fellowship program in Endocrinology and Metabolism in Canada where he spent two years and a half at the University of Alberta as a clinical fellow at the department of Endocrinology and Metabolism.
Dr. Alkaabi’s research interests are in diabetes mellitus, thyroid disorders, obesity, osteoporosis and Vitamin D deficiency. He has over 100 publications as articles and abstracts and various participations at international meetings and organizer of many scientific conferences and meetings.
Dr. Raya is a consultant endocrinologist at Tawam Hospital in Al Ain, United Arab Emirates. She obtained her MBBS from Faculty of Medicine and Heath Sciences-UAE University. She completed her internship and internal medicine residency in Tawam and Al Ain Hospitals in Al Ain city obtaining Arab Board Certification & MRCP certification. She had her fellowship training in Diabetes & Endocrinology at Imperial College Health Care NHS Trust, London, UK. Through her career, she has been in involved in medical education for pre and postgraduates.
Dr. Basaria is a Professor of Medicine at Harvard Medical School and Associate Director of the Section of Men’s Health, Aging and Metabolism at the Brigham and Women’s Hospital. He is a recognized leader in the field of Male Reproduction. His work has contributed to the understanding of cardiometabolic complications of androgen deprivation therapy in men with prostate cancer and the efficacy of testosterone replacement in men with opioid-induced androgen deficiency
FRCP, FACE, MSc diabetes, MSc (MPHE), SCE endocrine, ECNU, CHS
Is currently a consultant Endocrinologist at Dubai Hospital, he is a fellow of Royal college of physicians and the American college of endocrinology (FRCP, FACE). He is very active in under and postgraduate teaching and has a master degree in medical professional health education MSc (MHPE) as well as a master degree in diabetes from Cardiff university.
He is certified by the American college of Endocrinology in thyroid and neck USS (ECNU). He is an expert in thyroid and thyroid USS guided procedures and performed over the last 13 years more than 3500 procedures.
He shared in establishing the Sudanese Diabetes Association the Gulf Chapter in 2014 and is the current president of the chapter.
He is also a very active member of a research group and published more that 70 original papers and review articles. He coauthored three book chapters in Glucagon antagonists, history of GLP1 analogues and management of diabetes in Ramadan.
I am an Associate Professor of Medicine at the University of Minnesota. I am an academic adult endocrinologist who is engaged in clinical/translational research examining the effects of lifestyle interventions for management of obesity, insulin resistance, and prediabetes. Formally trained in clinical research, I have extensive experience (supported by NIH funding) conducting in vivo human studies with especially with lifestyle interventions (diet, exercise) and mechanistic physiological measures to evaluate outcomes. I am also Director of the Diabetes, Endocrinology Metabolism T32 training grant here at the University of Minnesota.
Kenneth Cusi, M.D., F.A.C.P., F.A.C.E.
Professor of Medicine
Chief, Division of Endocrinology, Diabetes and Metabolism at The University of Florida at Gainesville
Dr. Cusi is a Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at The University of Florida at Gainesville (2011-present). He is also a faculty and researcher at the Endocrinology, Diabetes and Metabolism Division at the Veterans Administration Medical Center at Gainesville, FL.
He received his medical degree and did his internal medicine residency in Buenos Aires, Argentina and completed a fellowship in Endocrinology, Diabetes and Metabolism at Baylor College of Medicine, Houston, Texas. He worked in San Antonio, Texas (1992-2011) on the role of defects in insulin secretion and insulin resistance to the development of type 2 diabetes mellitus (T2DM), as well as on complications associated with T2DM, focusing on the underlying mechanisms of nonalcoholic fatty liver disease (NAFLD) in T2DM and its impact on dyslipidemia, diabetes control and cardiovascular disease. Current work centers on understanding underlying pathways/mechanisms associated with NASH, promoting early screening strategies and searching for novel treatments, having participated in multiple clinical trials.
Dr. Cusi has published over 200 original articles, reviews and book chapters in a broad spectrum of peer-reviewed journals. He is a reviewer for many journals in the fields of endocrinology, metabolism, diabetes and liver disease and lecturer at national and international meetings on the role of obesity and T2DM in NAFLD. In 2015, Dr. Cusi received the Exemplary Teacher Award and the Clinical Research Award for outstanding achievement, research discovery, and productivity from the University of Florida at Gainesville. In 2020, he received the prestigious American Association of Clinical Endocrinologists Jack Baskin, MD, Endocrine Teaching Award. He has contributed to consensus statements and guidelines (AASLD 2012, 2018; ALEH 2020; AGA 2021). His current work is primarily funded by the National Institute of Health (NIH), but also from investigator-initiated and industry studies on new treatments for NASH. He has been a member of the NIH Clinical and Integrative Diabetes and Obesity (CIDO) study section (2016-2020).
Kate has been a qualified children’s nurse since 1994, and has worked in general paediatrics, paediatric ICU and neuroscience before specialising in paediatric endocrinology in 2000. She is also a qualified Children’s Advanced Nurse Practitioner, and a Nurse Teacher. She has become well-known internationally within paediatric endocrinology, having presented and published widely. Her experience as a Clinical Nurse Specialist in Paediatric Endocrinology has led her to work with some of the world’s leading experts across London, UK. She has sub-specialised in growth and puberty, neuro-endocrine late effects of childhood brain tumours, adrenal disorders and differences of sex development.
Kate has always been passionate about educating staff and students, and started at London South Bank University, London, UK, the UK leading University in training children’s nurses, as a Senior Lecturer in Children’s Nursing in September 2015. She launched the new BSc/MSc module ‘Principles of care for the child and young person in endocrinology’ in January 2017, and has run three successful intakes. She now leads the UK’s only paediatric Non Medical Prescribing programme, and is now Associate Professor in Paediatric Prescribing and Endocrinology
Dr. Drucker is an Endocrinologist and Professor of Medicine in the Division of Endocrinology at University of Toronto. He holds the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology. His laboratory is based in the Lunenfeld Tanenbaum Research Institute at Mount Sinai Hospital in Toronto and studies the molecular biology and physiology of the glucagon-like peptides
Ahmed Elhassan, M.D. is an Endocrinologist at Dubai Hospital – United Arab Emirates. He specializes in diabetes, obesity, and endocrine disorders.
After earning his medical degree at the University of Khartoum – Sudan. Dr Elhassan completed a residency in Internal Medicine at University of Illinois Chicago and St. Joseph hospital, Chicago, Illinois. He then completed Endocrinology fellowship at University of Texas Southwestern, Dallas, Texas.
Dr. Elhassan is American board certified in Internal Medicine, Endocrinology, Diabetes, and Metabolism, and Board Certified in Obesity medicine. He is an active member of several professional organizations, including Endocrine Society, and Emirates Diabetes Society.
His clinical practice and research focus on a multidisciplinary approach to patients with endocrine disorders, diabetes, and obesity.
Huda Ezzeddin Mustafa
Huda Ezzeddin Mustafa MBBS MSc. FRCP FACE ECNU
Consultant in Diabetes and Endocrinology
Director of Academic Affairs
HealthPlus Center for Diabetes and Endocrinology. Abu Dhabi, UAE
Adjunct Faculty, College of Medicine and Medical Sciences. UAE University
Adjunct Faculty, Khalifa University. Abu Dhabi. UAE
Huda E. Mustafa graduated from King Faisal University in Saudi Arabia and completed her postgraduate training in Internal Medicine and Endocrinology at Imperial College London, UK. She holds a Master’s degree in Diabetes from Warwick University, UK. and is a Fellow of the Royal College of Physicians of London and Edinburgh, as well as a Fellow of the American College of Endocrinology.
Dr. Huda has held several leading clinical and academic positions as she has been the Division Head of Endocrinology & Diabetes in Sheikh Khalifa Medical City and the Lead Physician of the thyroid cancer program and Bariatric Medicine. In 2019, Dr. Huda joint HealthPlus center of Diabetes and Endocrinology as a consultant in the field besides her role as a Director of Academic Affairs of Health plus network. Over the past 10 years she has been actively involved in various scientific and professional committees, medical education, as well as a reviewer for regional peer reviewed medical journals.
Her areas of interest include thyroidology, Diabetes, and Reproductive Endocrinology.
Dr. Fleming has been a registered nurse since 1998, and completed her Masters of Science in Nursing Education from Duke University and her PhD in Nursing from the University of North Carolina at Chapel Hill. She has worked in the hospital setting in critical care and emergency medicine. Dr. Fleming has done research at both Duke University and UNC’s schools of nursing concerning parental management of adrenal crisis in children with congenital adrenal hyperplasia (CAH) and has developed several educational tools related to adrenal crisis including a training video, a mobile health application, and numerous brochures regarding adrenal crisis prevention and management.
In addition to serving as the Associate Dean of Undergraduate Programs, Dr. Fleming teaches in the undergraduate and graduate programs and continues her program of research examining the intersection of family life and CAH. Her work has been featured in numerous peer reviewed academic journals, and she speaks both nationally and internationally on family management of CAH. She is also developing new models for the undergraduate capstone clinical experience with community partners. She serves on the Board of Trustees and is the Vice Chair of the CARES Foundation.
Dr. Jennifer Green is a professor of medicine in the division of endocrinology, metabolism, and nutrition at Duke University and a faculty member of the Duke Clinical Research Institute. Her research has focused upon strategies to treat diabetes mellitus and reduce the risk of cardiovascular, renal and other
diabetes-related complications. Her work with the DCRI has included protocol development, oversight of adjudication committees, and clinical and operational leadership for several large, international trials designed to determine the cardiovascular effects of glucose-lowering medications (TECOS, EXSCEL, and
Harmony Outcomes). She currently serves as US coordinating center PI and US national representative for the EMPA-Kidney trial of empagliflozin therapy in patients with chronic kidney disease. Dr. Green is also a member of the American Diabetes Association’s Professional Practice Committee, which publishes the organization’s annual Standards of Care in Diabetes.
Consultant Physician and Diabetologist; Dept of Internal Medicine; Diabetes Unit; Rashid Hospital, Dubai Health Authority
Dr. Khadija Hafidh has 20 years of experience in Internal medicine, diabetes, obesity, metabolism and medical education. Currently, she heads the Diabetes Unit at Rashid Hospital, Dubai Health Authority.
She is a Fellow of the Royal College of Physicians of Edinburgh, and a member of the American College of Physicians.
She is an Associate Professor and clinical tutor at Dubai Medical College
She is a member of the steering committee for the UAE national diabetes guidelines and editorial member of the Dubai Diabetes and Endocrine Journal
Her research interest includes: cardiovascular complications in diabetes and obesity
Dr Hassanein is a senior consultant in Endocrinology and Diabetes at Dubai Hospital, Dubai, UAE since 2014. He holds an Academic post of Senior Lecturer, and Associate Director for Postgraduate Diabetes Education, Cardiff University. UK since 2007and was appointed to the post of Consultant in the Department of Endocrinology and Diabetes at BCUHB, UK, in 2002. Dr Hassanein graduated from the Faculty of Medicine, Alexandria, Egypt.
His main research interest is in the field of diabetes and Ramadan. He co-authored recommendations papers on this subject for the American Diabetes Association (ADA) in 2005 and 2010, and for the British Medical Journal in 2010 as well as the IDF-DAR practical guidelines, 2016. Dr Hassanein has participated as the first author and/or a co-author in numerous studies in this field. He has published over 50 papers and has presented more than 30 oral presentations at national and international meetings.
Dr. Meg Keil is a clinical researcher and nurse practitioner with the National Institute of Child Health and Human Development at the National Institutes of Health in the United States of America. She received her PhD Nursing from the Uniformed Services University of the Health Sciences,is a graduate of University of Colorado and Georgetown University, and a Fellow in the American Academy of Nursing. Dr. Keil’s research focuses on bio-behavioral outcomes of early life adversity, pediatric Cushing syndrome, adrenal insufficiency, quality of life and other outcomes associated with chronic endocrine disorders in children. Dr. Keil has authored or co-authored numerous articles published in peer-reviewed journals on pediatric endocrine disorders, including Cushing syndrome, quality of life outcomes, congenital adrenal hyperplasia, obesity, and pituitary tumors. Dr. Keil has experience in leadership roles in professional nursing organizations, including PENS (Pediatric Endocrinology Nursing Society) and the European Society of Endocrinology Nurses Working Group.
Dr. Sami Kenz is consultant endocrinologist and he trained in Manchester UK (North Western Deanery). He obtained his CCT-UK in Endocrinology and Internal Medicine, MRCP-Endocrinology, and FRCP-Edinburgh. He was a Consultant Endocrinologist in UK before moving to UAE in 2015. Dr. Sami Kenz is currently working in Rashid Centre for Diabetes and Research, Ajman, UAE. He is Clinical Assistant Professor with University of Sharjah.
Dr. Kenz is a member of the Royal college of Physicians-UK, British Endocrine Society, Diabetes UK, and AACE-Gulf. Dr. Sami Kenz has publications as main author or co-author in peer-reviewed journals. He is currently involved in few research projects in Rashid Centre for diabetes. His prime areas if interest are Medical weight management, managing type 1 and type 2 Diabetes and General Endocrinology.
Professor of Medicine and Radiology and Chief of the Division of Endocrinology, Diabetes and Metabolism at the Perelman School of Medicine, University of Pennsylvania. Her clinical practice focuses on thyroid neoplasia. She was the fellowship Program Director at Penn for 20 years and a past President of the Association of Program Directors in Diabetes, Endocrinology, and Metabolism. Her research interests include sonography in the evaluation of patients with thyroid nodules and cancer. Dr. Mandel was on the writing group for the ATA Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer and is co-chairing the 2021 ATA Guidelines for Patients with Thyroid nodules. Dr. Mandel initiated the Ultrasound workshops for the ATA and Endocrine Society. Dr. Mandel has received the Endocrine Society’s Distinguished Educator Award and the 2019 ATA WIT Woman of the Year award. She is past President of the Endocrine Society. Dr. Mandel has over 90 peer reviewed publications in journals including the New England Journal of Medicine, JAMA and the Annals of Internal Medicine.
Mark E. Molitch, M.D. is Professor Emeritus in the Division of Endocrinology, Metabolism and Molecular Medicine at Northwestern University Feinberg School of Medicine in Chicago. His research has focused on the pathogenesis and treatment of pituitary tumors and the effects of such tumors on pregnancy. He has participated in the development of most of the medical treatments for prolactinomas and acromegaly and has been a member of the committees that wrote the Guidelines for the evaluation and treatment of Adult Growth Hormone Deficiency, of Pituitary Incidentalomas and of Acromegaly of The Endocrine Society and of Prolactinomas of The Pituitary Society. Dr. Molitch has authored more than 500 original papers, review articles, book chapters, case reports and other publications. He was an Endocrine Society Council Member 2008 – 2010, President of The Pituitary Society 2012-2013, was the 2013 recipient of the Distinguished Educator Award of The Endocrine Society and the 2020 recipient of the Lifetime Achievement Award of The Pituitary Society.
Kristen Nadeau, MD, MS is the University of Colorado Anschutz Medical Campus’s (CU-Anschutz) Research Director for Pediatric Endocrinology and for Bariatric Surgery, and CU-Anschutz’s NIH Diabetes Research Center’s Clinical Research Core Co-Chair. Her research focuses on understanding mechanisms of and training Jr. investigators in youth-onset diabetes and obesity to prevent long-term complications, using gold-standard clamp, isotope and MRI methods to study insulin sensitivity/secretion and comprehensive cardiovascular, circadian and hepatorenal phenotyping. As Pediatric Chair of NIDDK’s multi-center RISE study of β-cell preservation, and a cardio/renal/metabolic leader in NIDDK’s TODAY study, she helped demonstrate that youth-onset type 2 diabetes (T2D) is alarmingly more aggressive and treatment-resistant than adult-onset, now being addressed as MPI of a multi-site RO1 evaluating mechanisms and outcomes of bariatric surgery in youth-onset T2D, and Co-I of a multi-site gestational diabetes prevention R01 in American Indians. She also demonstrated that adjunctive metformin or bromocriptine improve insulin resistance and cardiovascular health in type 1 diabetes. In 2021 she was elected to the American Society for Clinical Investigation (ASCI) and received the American Diabetes Association (ADA’s) Outstanding Scientific Achievement Award.
Dr. Elizabeth N. Pearce received her undergraduate and medical degrees from Harvard and a masters’ degree in epidemiology from the Boston University School of Public Health. She completed her residency in internal medicine at Beth Israel Deaconess Medical Center, and her fellowship in endocrinology at Boston University. She is a Professor of Medicine at Boston University School of Medicine in the Section of Endocrinology, Diabetes, and Nutrition. She was the 2018-2019 President of the American Thyroid Association. She also serves as the Regional Coordinator for North America for the Iodine Global Network. She is an Associate Editor for Thyroid and the Journal of Clinical Endocrinology and Metabolism and has also served on multiple Editorial Boards including those for Clinical Endocrinology, Endocrine Practice, Clinical Thyroidology, and Lancet Diabetes & Endocrinology. She co-chaired the American Thyroid Association’s 2017 Thyroid in Pregnancy Guidelines Task Force. Her research interests include the sufficiency of dietary iodine in the U.S., thyroid function in pregnancy, the thyroid effects of environmental perchlorate exposure, and the cardiovascular effects of subclinical thyroid dysfunction. Dr. Pearce was the 2011 recipient of the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland and was the 2018 Women in Thyroidology Woman of the Year.
Dr. Fauzia Rashid graduated from Pakistan in 2000 with the role of honor .She worked as fellow endocrine in Karachi, Pakistan in 2006—2007 after her four years of residency and Masters in Internal medicine. Dr. Rashid did a MSc in Diabetes from university of South wales.
She is associated as a senior specialist in the department of diabetes and endocrinology in Dubai hospital since 2009.
She’s actively involved in teaching and research activities . Additionally, Dr. Rashid is serving as a section editor in the Dubai Journal of diabetes and endocrinology while also being a co-author to many publications in the field of diabetes and endocrinology.
Prof Teede is a clinically practising endocrinologist and leading academic in women’s reproductive and metabolic. She is Executive Director of Monash Partners Academic Health Sciences Centre and led the establishment and was inaugural chair of the Australian Health Research Alliance and the National Women’s Health Research Translation and Impact Network. She is the Director of the Monash Centre for Health Research and Implementation, School of Public Health, Monash University and an NHMRC Practitioner Fellow. Prof Teede has leadership roles in health care, research, translation, policy settings, national and international professional societies and the not for profit sector. She is past President of the Endocrine Society of Australian, sat on the National NHMRC Research Committee and is a member of the Academy of Health and Medical Sciences, the International Society of Endocrinology Executive and the US Endocrine Society Guideline task force. Helena has been recognised for her leadership with a US Endocrine Society Laureate award and has led Women in Medicine and Women in Leadership research and capacity building programs to engage and support women in career advancement and leadership. She has over 450 publications in women’s health and key contributions are in translation of evidence into practice and policy.
R. Michael Tuttle
Dr. R. Michael Tuttle, an Endocrinologist, Professor of Medicine, and Chief of the Endocrinology Service at Memorial Sloan Kettering Cancer Center in New York, designed and validated the first real time risk assessment model for thyroid cancer management in which individual risk estimates are modified over time as a function of response to initial therapy. His research continues to center on important management aspects of thyroid cancer including efforts to better define (1) the risk of recurrence and death from thyroid cancer for individual patients, (2) the role of active surveillance in properly selected patients with low-risk papillary thyroid cancer, and (3) the proper application of minimalistic management options to better tailor the intensity of therapy and follow-up to the risks of undesirable outcomes. His clinical practice is entirely devoted to the evaluation and management of patients with thyroid cancer.
Dr. Vaidya is the Director of the Center for Adrenal Disorders at Brigham and Women’s Hospital and an Associate Professor at Harvard Medical School. He oversees the multi-disciplinary clinical care of patients with adrenal diseases and runs a translational research program. His research has helped characterize the severity spectrum of primary aldosteronism, the optimal approaches to treating primary aldosteronism, the genetics of pheochromocytoma-paraganglioma syndromes, and the systemic consequences of adrenal tumors and hypercortisolism.
Dr. Adrian Vella is a Professor of Medicine in the Mayo Clinic College of Medicine and has been on staff at Mayo Clinic Rochester since June 2001. Dr. Vella is a graduate of the University of Malta Medical School (1993). He came to Rochester for his Internal Medicine Residency in 1995 and was subsequently accepted to the Clinician-Investigator track of Endocrine Fellowship training program and completed this in 2001, joining the consulting staff at Mayo Clinic. Currently, Dr. Vella directs a program funded by the National Institutes of Health aimed at understanding the pathogenesis of prediabetes and factors affecting islet function. His clinical interests include the diagnosis and management of hypoglycemic disorders.
Margaret E. Wierman MD, is a Professor of Medicine, Integrative Physiology at the University of Colorado School of Medicine where she directs the Pituitary and Adrenal Tumor Program. Dr. Wierman is a translational physician scientist whose research interest has been in reproductive endocrinology and sex hormone action, and more recently in the molecular mechanisms of pituitary tumors and adrenal cancer. She also directs the Program to Advance Gender Equity in the Department of Medicine. Dr. Wierman has a long track record in mentoring and pipeline development of academic researchers. She directs the K to R grant review and mock study section program at Colorado to aid junior investigators in obtaining their first R type award. She received the Women in Endocrinology Mentor Award and the Endocrine Society Laureate Mentor Award from the Endocrine Society. Dr. Wierman is the chair-elect for the International Society of Endocrinology.
Chris Yedinak is a Doctor of Nursing Practice and a board certified Family Nurse Practitioner. She is an Associate Professor at the Northwest Pituitary Center, Oregon Health & Sciences University, Portland, Oregon USA, where she has provided clinical diagnosis and management of patients with pituitary and adrenal dysfunction for the last 20 years.
Dr. Yedinak completed her undergraduate training in Australia and post a Graduate Diploma in Tertiary Education at University of Southern Queensland, Toowoomba. She completed her BSN post graduate and Doctoral Studies at Oregon Health & Sciences University, Portland Oregon.
Her research are focused on the quality of life, clinical outcome studies and the management of patients with chronic pituitary diseases. She has authored over 60 peer-reviewed articles, abstracts and book chapters and is author and co-editor of the first Advanced Practice in Endocrinology Nursing text book. She has presented her research at numerous scientific meetings worldwide and collaborates with patient organizations worldwide.
Dr. Yedinak is President of the Endocrine Nurses Association (USA), the Federation of International Nurses in Endocrinology (F.I.N.E.), a board member of the European Society of Endocrinology Nurse Committee and a medical advisor for the World Association of Pituitary Organizations (WAPO).